RIFAMPIN

Generic: RIFAMPIN

Fresenius Kabi USAManufacturer
INTRAVENOUSRoute
RIFAMPINActive Substance
2014-08-21Original Approval

RIFAMPIN is FDA application ANDA091181, sponsored by FRESENIUS KABI USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2022-07-28
Rifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore,

CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity.

Class II2015-06-04
Rifampin for Injection, USP 600mg/vial in a 20mL vial, Rx only, Manufactured for Fresenius Kabi LLC 3 Corporate Drive, L

Failed Impurities/Degradation Specifications; out-of-specification for color, impurity, and degradat

Class II2024-01-05
Rifampin Capsules USP 150mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryla

Subpotent Drug and Failed Impurities/Degradation Specifications

Class II2024-01-11
Rifampin Capsules USP, 150 mg, 30 Capsules (3 x 10) unit doses per carton, Rx Only, Distributed by: American Health Pack

Failed Impurities/Degradation Specification.

Class II2022-12-20
Rifampin Capsules USP, 300 mg, 100 Capsules (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Co

Failed Impurities/Degradations Specifications

Class II2024-01-05
Rifampin Capsules USP 300mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Marylan

Subpotent Drug and Failed Impurities/Degradation Specifications

Class II2022-04-07
Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morga

Failed Impurities/Degradation Specifications: High out of specification results obtained for related

Class II2022-12-12
Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, Maryland 212

Failed Impurities/Degradation Specifications: Failure observed in related substance testing during l

Class II2019-10-07
Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103; NDC 6

Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results

Top Reported Reactions

1
DRUG INEFFECTIVE
1,645 reports
2
OFF LABEL USE
1,253 reports
3
DRUG INTERACTION
1,133 reports
4
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
765 reports
5
NAUSEA
698 reports
6
CONDITION AGGRAVATED
634 reports
7
PRODUCT USE IN UNAPPROVED INDICATION
605 reports
8
PYREXIA
592 reports
9
VOMITING
497 reports
10
DRUG RESISTANCE
474 reports